1. Home
  2. Browse
  3. HRA003009
HRA003009
   HRA003009.xlsx
Title:
Subtypes and Drug Responses of Glioma Based on Patient-derived Cell Atlas
Release date:
2024-06-18
Description:
Glioblastoma (GBM) is the most common and currently incurable brain tumor. Despite the widely described heterogeneity of GBM, clinical therapy targeting different subtypes is deficient. Here, to characterize the drug responses of GBM with different subtypes, we generated a collection of patient-derived glioma cell lines (PDGCs), which retained the transcriptomic and genomic heterogeneity of their parental tissues.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA011142
Study type:
Disease Study
Disease name:
brain glioma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC001637
DAC name:
Chen Lab Data Access Committee
Contact person:
Chen Jian
Email:
chenjian@cibr.ac.cn
Description:
If you need to request access to this data set, please contact chenjian@cibr.ac.cn
Individuals & samples
Files
Request Data
Submitter:   Chen Jian / chenjian@cibr.ac.cn
Organization:   Chinese Institute for Brain Research
Submission date:   2022-08-11
Requests:   -